BR112015007647A2 - derivados de quetamina - Google Patents

derivados de quetamina

Info

Publication number
BR112015007647A2
BR112015007647A2 BR112015007647A BR112015007647A BR112015007647A2 BR 112015007647 A2 BR112015007647 A2 BR 112015007647A2 BR 112015007647 A BR112015007647 A BR 112015007647A BR 112015007647 A BR112015007647 A BR 112015007647A BR 112015007647 A2 BR112015007647 A2 BR 112015007647A2
Authority
BR
Brazil
Prior art keywords
ketamine derivatives
methods
derivatives
ketamine
formula
Prior art date
Application number
BR112015007647A
Other languages
English (en)
Inventor
Wallace Sleigh James
Jose Jiney
James Voss Logan
Gregory Harvey Martyn
Akuratiya Gamage Swarnalatha
Alexander Denny William
Original Assignee
Auckland Uniservices Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Auckland Uniservices Ltd filed Critical Auckland Uniservices Ltd
Publication of BR112015007647A2 publication Critical patent/BR112015007647A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/14—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of carbon skeletons containing rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/20—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)

Abstract

resumo patente de invenção: "derivados de quetamina". a presente invenção refere-se a derivados de quetamina da fórmula (i), composições farmacêuticas compreendendo os mesmos, e métodos para o tratamento da dor compreendendo administrar os mesmos, e seu uso na produção de medicamentos para tratamento da dor. a presente invenção também se refere a métodos para anestesiar e a métodos para sedar um indivíduo compreendendo a administração de derivados de quetamina da fórmula (ii).
BR112015007647A 2012-10-08 2013-10-08 derivados de quetamina BR112015007647A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ60288512 2012-10-08
NZ61120213 2013-05-28
PCT/IB2013/059191 WO2014057414A1 (en) 2012-10-08 2013-10-08 Ketamine derivatives

Publications (1)

Publication Number Publication Date
BR112015007647A2 true BR112015007647A2 (pt) 2017-07-04

Family

ID=50476991

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015007647A BR112015007647A2 (pt) 2012-10-08 2013-10-08 derivados de quetamina

Country Status (13)

Country Link
US (3) US20150259277A1 (pt)
EP (1) EP2903963A4 (pt)
JP (2) JP6309957B2 (pt)
KR (1) KR20150065873A (pt)
CN (1) CN104837810B (pt)
AU (1) AU2013328280B2 (pt)
BR (1) BR112015007647A2 (pt)
CA (1) CA2922340A1 (pt)
EA (1) EA201590697A1 (pt)
HK (1) HK1212673A1 (pt)
IN (1) IN2015DN03854A (pt)
MX (1) MX2015004362A (pt)
WO (1) WO2014057414A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150065873A (ko) * 2012-10-08 2015-06-15 오클랜드 유니서비시즈 리미티드 케타민 유도체
US20160332962A1 (en) * 2015-05-13 2016-11-17 Janssen Pharmaceutica Nv (s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine
EP3297620A4 (en) 2015-06-27 2019-01-09 Shenox Pharmaceuticals, LLC TRANSDERMAL DELIVERY SYSTEM FOR KETAMINE
US11111210B2 (en) 2015-11-18 2021-09-07 Spirify Pharma Inc. Phenyl cyclohexanone derivatives and methods of making and using them
US11827606B2 (en) 2015-11-18 2023-11-28 Spirify Pharma Inc. Phenyl cyclohexanone derivatives and methods of making and using them
CA3228060A1 (en) * 2016-03-25 2017-09-28 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Crystal forms and methods of synthesis of (2r, 6r)-hydroxynorketamine and (2s, 6s)-hydroxynorketamine
KR102556740B1 (ko) * 2018-01-10 2023-07-18 엑스더블유파마 리미티드 케타민의 전구약물, 및 이의 조성물 및 용도
EP3761970A4 (en) * 2018-03-26 2022-06-08 Cellix Bio Private Limited COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROLOGICAL DISEASES
JP2021527038A (ja) * 2018-06-04 2021-10-11 ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ （２ｒ，６ｒ）−ヒドロキシノルケタミンの合成および精製のためのプロセス
CN112125816A (zh) * 2020-03-17 2020-12-25 国药集团工业有限公司 一种氯胺酮、其衍生物或其盐的消旋化方法
KR20240027792A (ko) 2021-08-13 2024-03-04 엑스더블유파마 리미티드 케타민 유도체의 약제학적 조성물 및 경구 투여 형태
CN115677444A (zh) * 2022-10-26 2023-02-03 公安部第三研究所 同位素毒品代谢物标记化合物及其制备方法、用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3254124A (en) 1962-06-29 1966-05-31 Parke Davis & Co Aminoketones and methods for their production
GB1134146A (en) * 1967-09-15 1968-11-20 Parke Davis & Co New organic amines and methods for their production
US5019583A (en) 1989-02-15 1991-05-28 Glaxo Inc. N-phenyl-N-(4-piperidinyl)amides useful as analgesics
US5466700A (en) 1993-08-30 1995-11-14 Glaxo Wellcome Inc. Anesthetic use of N-phenyl-N-(4-piperidinyl)amides
US5866591A (en) 1996-09-11 1999-02-02 Glaxo Wellcome Inc. Stable formulations of remifentanil
IL150929A0 (en) * 2000-01-28 2003-06-24 Rohm & Haas Pharmaceutical compounds comprising a pharmaceutically active moiety and a moiety comprising a substituent that enhances its properties
US20040248963A1 (en) 2001-11-23 2004-12-09 Bueno Melendo Ana Belen Prodrugs of excitatory amino acids
EP1333023B1 (en) * 2002-01-31 2010-12-22 Randox Laboratories Ltd. Immunogens, antibodies and conjugates to ketamine and its metabolites
AU2003291037A1 (en) * 2002-11-18 2004-06-15 Yaupon Therapeutics, Inc. Analgesic uses of norketamine and ketamine/norketamine prodrugs
EP2792347A1 (en) 2005-09-28 2014-10-22 Auris Medical AG Pharmaceutical compositions for the treatment of inner ear disorders
JP2010525081A (ja) * 2007-04-26 2010-07-22 オースペックス・ファーマシューティカルズ・インコーポレイテッド 重水素標識ケタミン
JP6296985B2 (ja) 2011-10-14 2018-03-20 ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ うつ病及び神経障害性疼痛の治療における（２ｒ，６ｒ）−ヒドロキシノルケタミン、（ｓ）−デヒドロノルケタミン及び他の（ｒ，ｓ）−ケタミンの立体異性デヒドロ及びヒドロキシル化代謝生成物の使用
KR20150065873A (ko) * 2012-10-08 2015-06-15 오클랜드 유니서비시즈 리미티드 케타민 유도체

Also Published As

Publication number Publication date
IN2015DN03854A (pt) 2015-10-02
JP2018127466A (ja) 2018-08-16
WO2014057414A1 (en) 2014-04-17
US20190169113A1 (en) 2019-06-06
CN104837810A (zh) 2015-08-12
EP2903963A1 (en) 2015-08-12
JP2015535847A (ja) 2015-12-17
KR20150065873A (ko) 2015-06-15
EP2903963A4 (en) 2016-05-25
US20170190653A1 (en) 2017-07-06
CN104837810B (zh) 2019-08-06
US20150259277A1 (en) 2015-09-17
US10239825B2 (en) 2019-03-26
EA201590697A1 (ru) 2015-09-30
WO2014057414A9 (en) 2014-12-18
AU2013328280B2 (en) 2017-12-21
JP6309957B2 (ja) 2018-04-11
CA2922340A1 (en) 2014-04-17
HK1212673A1 (zh) 2016-06-17
AU2013328280A1 (en) 2015-05-14
MX2015004362A (es) 2015-12-08

Similar Documents

Publication Publication Date Title
BR112015007647A2 (pt) derivados de quetamina
BR112015012555A2 (pt) derivados de benzimidazol como antagonistas de ep4
ECSP14013217A (es) 4-imidazopiridazin-1-il-benzamidas y 4-imidazotriazin-1-il-benzamidas como inhibidores de btk.
CY1118379T1 (el) Αναστολεις ιου ηπατιτιδας c
BR112013021537A2 (pt) derivados de tiazolilpenil-benzenosulfonamido como inibidores da quinase
BR112015007366A2 (pt) derivados de acilaminopirimidina para o tratamento de infecções virais e outras doenças
CU24117B1 (es) Derivados de la piridina de tieno (2,3-b) como inhibidores virales de la réplica
BR112015004205A2 (pt) sulfamoil-arilamidas e o uso das mesmas como medicamentos para o tratamento da hepatite b
BR112015000578A2 (pt) moduladores da via do complemento e usos dos mesmos
EA201391029A1 (ru) Производные оксазина и их применение при лечении неврологических нарушений
BR112015020389A8 (pt) compostos carbazol úteis como inibidores de bromodomínio, seu uso, bem como composição e produto farmacêuticos compreendendo os mesmos
MX2014009757A (es) Derivados de isoindolina, composiciones farmaceuticas que los contienen y su uso en terapia.
BR112014011162A2 (pt) derivados purínicos para o tratamento de infecções virais
BR112013000059A2 (pt) derivados de piperidina e seus usos para o tratamento de distúrbios metabólicos
BR112015010908A2 (pt) derivado de pirrol sulfonamida, método de preparação para o mesmo e aplicação médica do mesmo
EA201490888A1 (ru) Новые производные пурина и их применение для лечения заболевания
BR112014016648A8 (pt) derivados policíclicos, processo de preparação e uso farmacêutico dos mesmos
BR112014015845A8 (pt) derivados de azetidina, composições farmacêuticas e seu uso
BR112014031091A2 (pt) Derivados de piperidina para agonista de gpr119
BR112013026397A2 (pt) Compostos cromenona como inibidores de pi 3-cinase para o tratamento de câncer
CR20140144A (es) Derivados de estra-1,3,5 (10), 16-tetraen-3-carboxamida, procedimientos para su preparación, preparados farmacéuticos que los contienen, así como su uso para la preparación de medicamentos
BR112014012459A2 (pt) 2h-indazóis como antagonistas do receptor de ep2
BR112014001908A2 (pt) derivados aza heterocíclicos substituídos
BR112015022758A2 (pt) derivados de pirrolidina, composições farmacêuticas contendo os mesmos e seu uso em terapia
BR112015001207A8 (pt) derivados de carbamato/ureia, seus usos, composição farmacêutica, forma livre e seu método de preparação

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B07E Notice of approval relating to section 229 industrial property law

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: suspension of the patent application procedure
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements